Latent Retrieval Augmented Generation of Cross-Domain Protein Binders
Zishen Zhang, Xiangzhe Kong, Wenbing Huang, Yang Liu
TL;DR
This work addresses the challenge of designing site-specific protein binders by marrying retrieval of known interfaces with generative design. It introduces RADiAnce, a retrieval-augmented diffusion framework that operates in a contrastive, cross-domain latent space to align binder and interface representations and guide generation with retrieved motifs. The approach delivers superior performance in both peptide and antibody codesign, demonstrates cross-domain benefits, and shows potential for de novo binder design without bound structures, highlighting practical impact for drug discovery. The study also analyzes retrieval quantity, proposes adaptive retrieval, and discusses reproducibility and data-split integrity to ensure robust benchmarking.
Abstract
Designing protein binders targeting specific sites, which requires to generate realistic and functional interaction patterns, is a fundamental challenge in drug discovery. Current structure-based generative models are limited in generating nterfaces with sufficient rationality and interpretability. In this paper, we propose Retrieval-Augmented Diffusion for Aligned interface (RADiAnce), a new framework that leverages known interfaces to guide the design of novel binders. By unifying retrieval and generation in a shared contrastive latent space, our model efficiently identifies relevant interfaces for a given binding site and seamlessly integrates them through a conditional latent diffusion generator, enabling cross-domain interface transfer. Extensive exeriments show that RADiAnce significantly outperforms baseline models across multiple metrics, including binding affinity and recovery of geometries and interactions. Additional experimental results validate cross-domain generalization, demonstrating that retrieving interfaces from diverse domains, such as peptides, antibodies, and protein fragments, enhances the generation performance of binders for other domains. Our work establishes a new paradigm for protein binder design that successfully bridges retrieval-based knowledge and generative AI, opening new possibilities for drug discovery.
